Last week the La Jolla Institute for Allergy & Immunology announced that it will develop San Diego’s first Center for RNAi screening — a breakthrough genomics technology that will further enhance San Diego’s reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.
The National Institutes of Health awarded the La Jolla Institute $12.6 million to develop the Center.“RNAi (RNA interference) allows scientists to explore new ways of disrupting disease processes based on altering gene function,” said Mitchell Kronenberg, Ph.D., La Jolla Institute president and chief scientific officer. “It is a powerful technology with the potential to transform human health and we are pleased that the NIH has entrusted us with bringing the first publically funded RNAi facility to San Diego.”
RNAi has been heralded as a revolutionary technology because it opens the door to developing new therapies for cancer and other diseases based on silencing specific genes. Its discoverers were awarded the 2006 Nobel Prize for Physiology or Medicine.
It is generally regarded as one of the most promising drug discovery technologies available today. Scientists from all medical fields can advance their research using RNAi.
For more information see the full press release here